Evidence map›Paper›PMID 39064695›Full record

ArticleNutrients2024

Dietary LPC-Bound

Eva C Hermans, Carlon C E van Gerven, Line Johnsen, Jørn E Tungen, Cora H Nijboer, Caroline G M de Theije

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eva C HermansDepartment for Developmental Origins of Disease, University Medical Center Utrecht Brain Center and Wilhelmina Children's Hospital, Utrecht University, 3508 AB Utrecht, The Netherlands.
Carlon C E van GervenDepartment for Developmental Origins of Disease, University Medical Center Utrecht Brain Center and Wilhelmina Children's Hospital, Utrecht University, 3508 AB Utrecht, The Netherlands.ORCID 0009-0008-8709-7963
Line JohnsenAker BioMarine Human Ingredients AS, Oksenøyveien 10, 1327 Lysaker, Norway.
Jørn E TungenAker BioMarine Human Ingredients AS, Oksenøyveien 10, 1327 Lysaker, Norway.
Cora H NijboerDepartment for Developmental Origins of Disease, University Medical Center Utrecht Brain Center and Wilhelmina Children's Hospital, Utrecht University, 3508 AB Utrecht, The Netherlands.
Caroline G M de TheijeDepartment for Developmental Origins of Disease, University Medical Center Utrecht Brain Center and Wilhelmina Children's Hospital, Utrecht University, 3508 AB Utrecht, The Netherlands.ORCID 0000-0003-1265-7897

Funding

Wilhelmina Children's Hospital Advances in cell-based therapy for the injured newborn brain: Optimizing nurture, habitat and momentum of mesenchymal stem cells
6 · The paper itself

Abstract

Neonatal hypoxic-ischemic (HI) brain injury is a prominent cause of neurological morbidity, urging the development of novel therapies. Interventions with

Indexed as

Animals, NewbornFatty Acids, Omega-3Hypoxia-Ischemia, BrainLysophosphatidylcholinesMesenchymal Stem Cell TransplantationMice, Inbred C57BLAnimalsBrainBrain InjuriesDietary SupplementsDisease Models, AnimalMaleMesenchymal Stem CellsMiceMyelin Basic ProteinNeuroprotective AgentsFatty Acids, Omega-3LysophosphatidylcholinesMbp protein, mouseMyelin Basic ProteinNeuroprotective Agentsintranasalkrill oilLPC-DHALPC-EPALysovetamesenchymal stem cell therapyneonatal hypoxic-ischemic brain injuryneuroprotectionoral supplementationoxidative stress

Identifiers

PMID39064695
PMCPMC11279425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.